Key facts
- This page summarizes Edward Harris Fenster's Form 4 filing for Sunrun Inc. (RUN).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Feb 2026, 17:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Gift
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 3, 2025.
Footnote F2
Shares sold only to cover exercise price and tax obligation upon the exercise of a stock option.
Footnote F3
Price represents the weighted average sale price of the shares sold. The sale price ranged from $19.30 to $20.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Footnote F4
Price represents the weighted average sale price of the shares sold. The sale price ranged from $20.30 to $21.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Footnote F5
Shares held following the reported transactions include 3,184 restricted stock units, which are subject to forfeiture until they vest.
Footnote F6
The shares subject to the option are fully vested and exercisable. The option had a 10-year exercise period with an expiration date of February 11, 2026.